全球医生药用化妆品市场：按产品类型、应用和地区分類的规模和预测

医师药用化妆品的市场规模与预测

预计 2024 年医师药用化妆品市场规模将达到 95.9 亿美元，到 2032 年将达到 190.8 亿美元，2026 年至 2032 年的复合年增长率为 8.98%。

人们对美的本质和前景以及抗衰老的认识不断提高，预计将推动医生派遣药用化妆品市场的成长。预计在预测期内，人们对医生药用化妆品的安全性和有效性的认识不断提高，以及消费者对各种皮肤问题的具体解决方案（如减少老龄化斑和痤疮疤痕）的需求不断增长等因素将进一步推动医生药用化妆品市场的增长。

定义医师药用化妆品的全球市场

药用化妆品是含有药用成分的化妆品。这些产品不需要法律检验。医生药用化妆品是仅透过医学指示的企业提供的化妆品，旨在对角质层以下的皮肤产生实际的生物学作用。许多选择配製这些药用化妆品的医生都有涉及皮肤健康的实践或专长。医生药用化妆品产品包括护肤、眼部护理产品和头髮护理产品。

这些产品专门针对老化征兆、感染疾病和其他个人外观问题而设计。医生药用化妆品是指仅透过医学指示的企业提供的产品，旨在对角质层下的皮肤产生实际的生物学作用。医师药用化妆品包括由皮肤科医师、毛髮学家、整形外科医师和其他医疗相关人员配製的药用化妆品。

全球医生药用化妆品市场概览

人们越来越重视美丽和外表，以及抗衰老意识的不断增强，是预计推动全球医生药用化妆品市场成长的关键因素。此外，人们对医生药用化妆品的安全性和有效性的认识不断提高以及新产品的推出也是推动全球市场成长的其他因素。

此外，医生药用化妆品是订製产品，比普通的非处方产品更能渗透到皮肤深处。

这些产品具有更深的渗透力，因此可以提供更好的早期效果，这是推动该市场成长的主要因素。大多数医美产品都是由医生、皮肤专家和科学家设计和配製的，他们花费数年时间研究成分，并在自己的诊所中实施，以治疗预期目标。此外，美丽和外表的日益重要、抗衰老意识的不断增强以及对医生药用化妆品的安全性和有效性的认识不断增强也是推动市场增长的因素。

目录

第一章：全球医师药用化妆品市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球医师药用化妆品市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章 全球医师配製的药用化妆品市场（依产品类型划分）

• 概述
• 护肤产品
• 护髮产品
• 眼部护理产品

第六章 全球医师药用化妆品市场（依应用）

• 概述
• 医院药房
• 零售药局
• 网上销售

第七章 全球医生药用化妆品市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第八章全球医师药用化妆品市场的竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第九章 公司简介

• Johnson & Johnson
• Allergan plc
• Procter & Gamble Co.
• Jan Marini Skin Research, Inc.
• L'Oreal SA
• Bausch Health Companies Inc.
• Unilever plc
• ZO Skin Health Inc.
• Obagi Cosmeceuticals LLC
• Merz Pharma

第十章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十一章 附录

• 相关调查

Physician Dispensed Cosmeceuticals Market Size And Forecast

Physician Dispensed Cosmeceuticals Market size was valued at USD 9.59 Billion in 2024 and is projected to reach USD 19.08 Billion by 2032, growing at a CAGR of 8.98% from 2026 to 2032.

The growing of essence of beauty and outlook, and the increasing consciousness about anti-aging, will encourage the growth of the Physician Dispensed Cosmeceuticals Market. Factors such as the growing knowledge about the security and effectiveness of Physician Dispensed Cosmeceuticals and escalating disposition of users towards a certain solution to diverse skin problems about age spot or acne spot reduction are anticipated to further propel the growth of the Physician Dispensed Cosmeceuticals Market during the forecast period.

Global Physician Dispensed Cosmeceuticals Market Definition

Cosmeceuticals are cosmetics that consist of medicinal properties. These products do not require any legal verification. Physician Dispensed Cosmeceuticals are cosmetic products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. There are many physicians who choose to dispense these cosmeceuticals whose practices or specialties involve skin health. Physician Dispensed Cosmeceuticals involve the products such as skin care, eye care, hair care products, and others.

These products are specially designed to target the signs of aging, infections, and other personal appearances. Physician Dispensed Cosmeceuticals refer to products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. Physician Dispensed Cosmeceuticals include medicated aesthetic products referred by dermatologists, trichologists, cosmetic surgeons, and allied medical professionals.

Global Physician Dispensed Cosmeceuticals Market Overview

Rising importance regarding beauty and appearance and increasing awareness about anti-aging are the primary factors expected to fuel the growth of the Global Physician Dispensed Cosmeceuticals Market. Furthermore, increasing awareness regarding the safety and efficacy of physician-dispensed cosmeceuticals and new product launches are other factors contributing to the growth of the global market.

Moreover, Physician Dispensed Cosmeceuticals are custom-made products that penetrate deeper into the skin than normal OTC products.

As these products are deeply penetrated, it provides early and better results which is the prime factor responsible for the growth of this market. Most Physician lines are designed and formulated by physicians, skin professionals, and scientists who have researched ingredients for many years and put them into action in their own practices to treat intended targets. Additionally, the increasing importance of beauty and appearance, growing awareness about anti-aging, and increasing awareness about the safety and efficacy of physician-dispensed cosmeceuticals are the other factors that are contributing to the growth of the market.

Global Physician Dispensed Cosmeceuticals Market: Segmentation Analysis

The Global Physician Dispensed Cosmeceuticals Market is segmented on the basis of Product Type, Application, and Geography.

Physician Dispensed Cosmeceuticals Market, By Product Type

• Skin care products
• Hair care products
• Eye care products

Based on Product Type, the market is bifurcated into Skin care products, Hair care products, and Eye care products. The skincare products segment accounted for a prominent share of the Global Physician Dispensed Cosmeceuticals Market in 2022, as the nature of cosmeceuticals demanded by consumers is largely to treat dermatological conditions. Increasing awareness about personal maintenance among the geriatric population and changing attitudes of middle-aged and geriatric populations in developing countries have fuelled the demand for cosmeceuticals in order to eliminate the outward signs of aging.

Physician Dispensed Cosmeceuticals Market, By Application

• Hospital Pharmacy
• Retail Pharmacy
• Online Sales

Based on the Application, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, and Online Sales.

Physician Dispensed Cosmeceuticals Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
• On the basis of Regional Analysis, The Global Physician Dispensed Cosmeceuticals Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific region is expected to grow significantly over the forecast period. A growing preference to behold long-lasting youthful appearance and beauty is driving the demand for effective physician-dispensed cosmeceuticals in the region. Furthermore, the growing focus of key market players on expansion in Asia Pacific countries, the huge customer base in the region, and rising awareness about physician-dispensed cosmeceuticals will also drive the market in the Asia Pacific.

Key Players

The "Global Physician Dispensed Cosmeceuticals Market" study report will provide valuable insight emphasizing the global market. The major players in the market are Johnson & Johnson, Allergan plc, Procter & Gamble Co., Jan Marini Skin Research, Inc., L'Oreal S.A., Bausch Health Companies Inc., Unilever plc, ZO Skin Health Inc., Merz Pharma, and Obagi Cosmeceuticals LLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In 2019, Galderma, a leading player in the physician-dispensed cosmeceuticals market, announced a partnership with Colorescience, a cosmetics company that specializes in mineral-based sunscreens and other skincare products. The partnership aimed to offer a wider range of skincare options to patients and consumers.
• In October 2021, Huons Biopharma signed a contract worth 97.2 billion won with German-based pharmaceutical company Haemato Pharm to distribute its botulinum toxin product exclusively to the European market. Thus, such instances show an increase in demand for physician-dispensed cosmeceuticals, which is ultimately driving market growth.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into Active, Cutting Edge, Emerging, and Innovators categories.
• Market Attractiveness
• The image of market attractiveness provided further helps to get information about the region leading in the Global Physician Dispensed Cosmeceuticals Market. We cover the major impacting factors driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Physician Dispensed Cosmeceuticals Market, gauge the attractiveness of a particular sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Skin care products
• 5.3 Hair care products
• 5.4 Eye care products

6 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hospital Pharmacy
• 6.3 Retail Pharmacy
• 6.4 Online Sales

7 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Johnson & Johnson
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Allergan plc
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Procter & Gamble Co.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Jan Marini Skin Research, Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 L'Oreal S.A.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Bausch Health Companies Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Unilever plc
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 ZO Skin Health Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Obagi Cosmeceuticals LLC
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Merz Pharma
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research